The best magazine
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
AIDS & HIV : Health & Medical
Nonoccupational Postexposure Prophylaxis for HIV Prevention
There have been many challenges with the implementation of HIV nonoccupational postexposure prophylaxis. What new solutions are on the horizon?
ART Adherence Support: Recommendations and Future Directions
There are many new strategies and approaches for promoting ART adherence. What is working and what focus should we take in the future?
Immunotherapy in Nonmelanoma Skin Cancer
Find out more about new immunotherapeutic approaches for the treatment of recurrent or multiple nonmelanoma skin tumors.
HIV Home Treatment
Being diagnosed with HIV was once one of the most dreaded conditions that one could face. It was an incurable, barely treatable disease from which death did not come gracefully. Over 25 years into the epidemic, ideas about HIV and AIDS have changed drastically. HIV remains incurable, but it is not u
Association of HIV Viral Load and CD4 Cell Count With HPV
A higher CD4 cell count after ART in HIV-positive women may have an impact on the control of HPV infection.
Viral Load Monitoring and Outcomes in HAART Patients
Do patients with negative PCR results have better virological outcomes than those with PVL < 40 copies/mL but detectable viraemia?
HIV/AIDS Surveillance: Commentary by Dr. John G. Bartlett -- May 2007
In this review and commentary: a comprehensive tabulation of HIV/AIDS surveillance data from the Kaiser Family Foundation, including data of importance with respect to opt-out testing.
Repeat Antenatal HIV Testing in the Third Trimester
Should a repeat HIV test be performed in the third-trimester of pregnancy?
Editorial - Compliance With Antiretroviral Regimens
Announcement of the pending release of new treatment guidelines, made at the 8th Conference on Retroviruses and Opportunistic Infections held this year in Chicago from February 4 through 8, was not unexpected.
Influenza Vaccination in Immunocompromised Patients
Learn about the clinical significance of the influenza virus infection and vaccine safety in HIV infected individuals, solid-organ and stem-cell transplant recipients and patients receiving biological agents.
HIV End-Stage Symptoms
Human Immunodeficiency Virus (HIV) is the virus that causes AIDS. After acute HIV infection and a long latency phase, HIV disease enters its two final stages: symptomatic infection and AIDS. These are marked by specific symptoms that indicate that the immune system is becoming progressively weakene
10 Facts About AIDS
According to UNAIDS, AIDS stands for acquired immunodeficiency syndrome and is the term used for advanced versions of the HIV infection. AIDS is such a dangerous condition because most people do not know when they have contracted it. There is currently no cure for AIDS, and millions of...
Ask the Experts - HIV-2 in the United States?
I have heard that recent epidemiology studies have shown that approximately 10% of HIV infections in the USA are with HIV-2, but are mainly undetected. When should a clinician test for HIV-2? Where can I obtain additional information on HIV-2 in the USA?
GI and Hepatic Diseases Associated With HIV
Gastrointestinal and hepatic diseases have been a significant problem in HIV-infected patients since the initial cases of HIV/AIDS were diagnosed.
Immunotherapy of Allergic Contact Dermatitis
How effective is the controlled administration of sensitizing haptens in treating allergic contact dermatitis?
How Is Rapid HIV Testing Performed?
SamplingIn rapid HIV testing, a sample of blood or oral fluid (which is not the same as saliva) can be used, according to Avert.org. According to the Centers for Disease Control and Prevention (CDC), this can be collected from a finger stick (using a small, very sharp instrument to induce...
Is PrEP Ready for Prime Time Use in HIV Prevention Research?
Is preexposure prophylaxis ready to be considered a standard of HIV prevention in research?
Preventing HIV Infection Among Sexual Assault Survivors
How can we improve HIV post-exposure prophylaxis adherence for sexual assault survivors?